Kim Lorence H. 4/A
4/A · Moderna, Inc. · Filed Jun 4, 2020
Insider Transaction Report
Form 4/AAmended
Moderna, Inc.MRNA
Kim Lorence H.
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-05-15$63.80/sh−2,600$165,880→ 1,219,910 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on September 18, 2019.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.